Supplier qualification is often treated as an approval exercise: collect a questionnaire, review a certificate, complete an audit and add the organization to an approved supplier list.
But supplier risk does not end when a purchase order is issued.
A supplier's process, manufacturing site, materials, personnel, information systems or subcontracting arrangements may change over time. A supplier that initially meets requirements can later introduce risks through uncontrolled changes or recurring performance problems.
An effective supplier management program therefore needs to cover the complete relationship, from selection to eventual exit.
Begin with the product and the risk
The first question should not be, "Does this supplier have a valid quality certificate?"
It should be, "What could happen to our product, process or patient if this supplier fails to meet its requirements?"
The answer determines how much qualification evidence and oversight are justified.
A supplier of general office stationery does not normally present the same product-quality risk as a contract manufacturer of sterile drug products or a manufacturer of a critical medical device component.
A practical risk assessment can consider:
- The impact of supplier failure on product safety, quality or regulatory compliance.
- Whether defects would be detected before the supplied item is used.
- The complexity and variability of the supplied process.
- Supplier experience and historical performance.
- The availability of alternative qualified sources.
- Dependence on subcontractors and critical materials.
- The difficulty of identifying and controlling supplier changes.
The purpose is to allocate oversight in proportion to meaningful risk, not to generate a complicated scoring system.
ICH Q9(R1) Quality Risk Management describes principles and tools that pharmaceutical manufacturers can apply to risk-based decisions.
It is guidance, not a universal legal mandate to use a particular numerical supplier-scoring formula.
Understand which regulations apply
Supplier obligations vary depending on the regulated product and jurisdiction.
For US medical device manufacturers, the FDA Quality Management System Regulation (QMSR) became effective on February 2, 2026. It incorporates ISO 13485:2016 by reference into 21 CFR Part 820, subject to the regulation's provisions.
FDA explains this framework on its QMSR information page.
Accordingly, medical device supplier-control procedures should reflect the current QMSR framework rather than relying exclusively on historical references to former 21 CFR 820.50 purchasing controls.
Pharmaceutical manufacturers must consider their applicable CGMP obligations, including the controls relevant to starting materials, components, contractors and manufacturing arrangements.
ICH Q10 also describes a pharmaceutical quality system model encompassing outsourced activities and purchased materials.
See the FDA's ICH Q10 guidance.
The regulatory expectations are not identical for every supplier, so a single generic checklist should not replace product-specific assessment.
Select suppliers using relevant evidence
A supplier evaluation should build a documented picture of capability.
Potential evidence includes the supplier's quality management system, manufacturing capability, technical specifications, personnel competence, inspection history, change-control arrangements and ability to meet the purchaser's requirements.
For a critical contract manufacturer, a site audit may provide valuable evidence.
For a lower-risk supplier, a properly evaluated questionnaire, technical review and performance history might be appropriate.
The assessment method should follow the risk rather than a fixed rule that every supplier must receive an annual on-site audit.
Equally, audit reports should not be accepted uncritically.
A report from another organization may be useful, but its scope, date, findings, auditor competence and relevance to the outsourced activity need evaluation.
The purchasing organization remains responsible for deciding whether the evidence is sufficient for its intended use.
Write quality agreements that clarify responsibilities
A quality agreement should describe how the parties manage activities that affect product quality.
It should be operationally useful, not merely a document signed during onboarding.
Depending on the relationship, important subjects may include:
- Product specifications and agreed acceptance criteria.
- Responsibilities for testing, release and disposition.
- Deviation and nonconformance notification.
- Investigation and CAPA ownership.
- Change-control approval and communication.
- Complaint handling and recall coordination.
- Documentation, record retention and data access.
- Audit rights and subcontracting arrangements.
- Escalation routes and contact responsibilities.
Consider a hypothetical contract manufacturer that plans to change a process parameter.
If the agreement does not clearly establish which changes require customer notification or prior approval, the legal manufacturer or product owner may learn of the change only after affected product is supplied.
A well-designed agreement reduces ambiguity by establishing responsibilities and escalation arrangements in advance.
It should be reviewed when the relationship or outsourced activities materially change.
Build a supplier scorecard that drives decisions
A supplier scorecard should support decisions, not simply display attractive percentages.
Useful performance indicators may include:
Delivery performance: Are materials or services supplied when required?
Product conformity: How frequently are incoming items rejected or found nonconforming?
Deviation handling: Does the supplier investigate problems promptly and provide credible findings?
Change management: Are relevant changes communicated and evaluated before implementation?
Corrective action effectiveness: Do corrective actions address the underlying problems?
Regulatory and quality-system signals: Have audit findings or other credible concerns affected confidence in the supplier?
The metrics should be relevant to the supplied product or service.
For example, an excellent on-time delivery rate cannot compensate for repeated failures involving a critical sterile component.
Scorecards should therefore combine quantitative performance with documented technical and quality judgment.
Know when to escalate
Supplier problems should not automatically produce identical actions.
A minor isolated delivery delay may require routine communication.
Repeated component defects may justify a formal improvement plan, additional incoming testing, a targeted audit or reconsideration of approval status.
A critical quality failure may require immediate containment, product impact assessment and restrictions on further supply.
The escalation process should consider the severity of the problem, affected products, existing controls and the supplier's ability to demonstrate sustainable improvement.
Hypothetical example: A supplier of molded device components has three successive lots rejected for dimensional failures.
Simply raising the incoming inspection sample size may improve detection but does not necessarily correct the supplier's manufacturing problem.
The purchasing organization could require evidence of process investigation, revised process controls, appropriate verification and a defined period of enhanced monitoring.
The resulting decision should be documented and reviewed.
Plan for supplier changes and exits
Supplier relationships can end because of commercial decisions, persistent performance failures, site closures or changes in manufacturing strategy.
An exit plan should address more than identifying a replacement vendor.
Depending on the circumstances, it may need to cover qualification of the new supplier, equivalence of materials, process validation or verification, inventory disposition, documentation transfer, change approvals and regulatory impact.
For a sole-source critical component, the transition may require substantial planning.
A supplier exit performed without effective technical review can introduce the very quality risks the change was intended to resolve.
Practical takeaway
A useful supplier program can be reviewed through five questions:
- Do we understand the product-quality risk associated with this supplier?
- Is qualification evidence appropriate to that risk?
- Are technical and quality responsibilities clearly assigned?
- Does ongoing performance information lead to meaningful decisions?
- Can we control supplier changes, failures and transitions?
If the organization cannot answer these questions with current records, the approved supplier list may not reflect actual supplier control.
Explore the related EduCraft course
EduCraft's Supplier and Contract Manufacturer Management Course addresses supplier strategy, qualification, risk assessment, quality agreements, performance monitoring, assessments and supplier transitions. Review its course page to confirm current availability.
